메뉴 건너뛰기




Volumn 10, Issue 3, 2006, Pages 653-663

Portopulmonary Hypertension

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BONE MORPHOGENETIC PROTEIN 2; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ILOPROST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; SEROTONIN; SILDENAFIL; UNIPROST; WARFARIN;

EID: 33845293378     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2006.08.023     Document Type: Review
Times cited : (17)

References (73)
  • 1
    • 2942522878 scopus 로고    scopus 로고
    • Clinical classification of pulmonary hypertension
    • Simonneau G., Galie N., Rubin L., et al. Clinical classification of pulmonary hypertension. J Am Coll Cariol 43 (2004) 5S-12S
    • (2004) J Am Coll Cariol , vol.43
    • Simonneau, G.1    Galie, N.2    Rubin, L.3
  • 2
    • 0037332028 scopus 로고    scopus 로고
    • Portopulmonary hypertension: a tale of two circulations
    • Budhiraja R., and Hassoun P.M. Portopulmonary hypertension: a tale of two circulations. Chest 123 (2003) 562-576
    • (2003) Chest , vol.123 , pp. 562-576
    • Budhiraja, R.1    Hassoun, P.M.2
  • 4
    • 8644222717 scopus 로고    scopus 로고
    • Portopulmonary hypertension: diagnostic advances and caveats
    • Krowka M.J. Portopulmonary hypertension: diagnostic advances and caveats. Liver Transpl 9 (2003) 1336-1337
    • (2003) Liver Transpl , vol.9 , pp. 1336-1337
    • Krowka, M.J.1
  • 5
    • 0345524985 scopus 로고
    • Pulmonary hypertension associated with hepatic cirrhosis
    • Fishman A.P. (Ed), University of Pennsylvania Press, Philadelphia
    • Groves B.M., Brundage B.H., Elliot C.G., et al. Pulmonary hypertension associated with hepatic cirrhosis. In: Fishman A.P. (Ed). The pulmonary circulation: normal and abnormal (1990), University of Pennsylvania Press, Philadelphia 359-369
    • (1990) The pulmonary circulation: normal and abnormal , pp. 359-369
    • Groves, B.M.1    Brundage, B.H.2    Elliot, C.G.3
  • 6
    • 0023615359 scopus 로고
    • Primary pulmonary hypertension: a national prospective study
    • Rich S., Dantzker D.R., Ayres S.M., et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 107 (1987) 216-223
    • (1987) Ann Intern Med , vol.107 , pp. 216-223
    • Rich, S.1    Dantzker, D.R.2    Ayres, S.M.3
  • 7
    • 0029875388 scopus 로고    scopus 로고
    • Pulmonary hypertension in chronic liver disease
    • Mandell M.S., and Groves B.M. Pulmonary hypertension in chronic liver disease. Clin Chest Med 17 (1996) 17-33
    • (1996) Clin Chest Med , vol.17 , pp. 17-33
    • Mandell, M.S.1    Groves, B.M.2
  • 8
    • 10744230826 scopus 로고    scopus 로고
    • Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database
    • Krowka M.J., Mandell S., Ramsay M.A., et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 10 (2004) 174-182
    • (2004) Liver Transpl , vol.10 , pp. 174-182
    • Krowka, M.J.1    Mandell, S.2    Ramsay, M.A.3
  • 9
    • 0023473478 scopus 로고
    • Coexistent pulmonary and portal hypertension: morphologic and clinical features
    • Edwards B.S., Weir E.K., Edwards M.D., et al. Coexistent pulmonary and portal hypertension: morphologic and clinical features. J Am Coll Cardiol 10 (1987) 1233-1238
    • (1987) J Am Coll Cardiol , vol.10 , pp. 1233-1238
    • Edwards, B.S.1    Weir, E.K.2    Edwards, M.D.3
  • 10
    • 0029876433 scopus 로고    scopus 로고
    • Structural and pathologic changes in the lung vasculature in chronic liver disease
    • Schraufnagel D.E., and Kay J.M. Structural and pathologic changes in the lung vasculature in chronic liver disease. Clin Chest Med 17 (1996) 1-15
    • (1996) Clin Chest Med , vol.17 , pp. 1-15
    • Schraufnagel, D.E.1    Kay, J.M.2
  • 11
    • 0007694758 scopus 로고
    • Primary pulmonary hypertension and coexisting portal hypertension. A retrospective study of six cases
    • Naeye R.L. Primary pulmonary hypertension and coexisting portal hypertension. A retrospective study of six cases. Circulation 22 (1960) 376-384
    • (1960) Circulation , vol.22 , pp. 376-384
    • Naeye, R.L.1
  • 12
    • 0032031727 scopus 로고    scopus 로고
    • Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension
    • Lee S.D., Shroyer K.R., Markham N.E., et al. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 101 (1998) 927-934
    • (1998) J Clin Invest , vol.101 , pp. 927-934
    • Lee, S.D.1    Shroyer, K.R.2    Markham, N.E.3
  • 13
    • 0033609066 scopus 로고    scopus 로고
    • Portopulmonary hypertension and the liver transplant candidate
    • Kuo P.C., Plotkin J.S., Gaine S., et al. Portopulmonary hypertension and the liver transplant candidate. Transplantation 67 (1999) 1087-1093
    • (1999) Transplantation , vol.67 , pp. 1087-1093
    • Kuo, P.C.1    Plotkin, J.S.2    Gaine, S.3
  • 14
    • 0018907242 scopus 로고
    • Plexogenic arteriopathy and liver cirrhosis
    • Ruttner J.R., Bartschi J.P., Niedermann R., et al. Plexogenic arteriopathy and liver cirrhosis. Thorax 35 (1980) 133-136
    • (1980) Thorax , vol.35 , pp. 133-136
    • Ruttner, J.R.1    Bartschi, J.P.2    Niedermann, R.3
  • 15
    • 0028085252 scopus 로고
    • Histopathology of primary pulmonary hypertension
    • Pietra G.G. Histopathology of primary pulmonary hypertension. Chest 105 (1994) 2S-6S
    • (1994) Chest , vol.105
    • Pietra, G.G.1
  • 16
    • 0032777126 scopus 로고    scopus 로고
    • Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers: evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth
    • Cool C.D., Stewart J.S., Werahera P., et al. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers: evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 155 (1999) 411-419
    • (1999) Am J Pathol , vol.155 , pp. 411-419
    • Cool, C.D.1    Stewart, J.S.2    Werahera, P.3
  • 17
    • 0025090770 scopus 로고
    • Distribution of arterial lesions and collateral pathways in the pulmonary hypertension of congenital heart disease: a computer aided reconstruction study
    • Yaginuma G., Mohri H., and Takahashi T. Distribution of arterial lesions and collateral pathways in the pulmonary hypertension of congenital heart disease: a computer aided reconstruction study. Thorax 45 (1990) 586-590
    • (1990) Thorax , vol.45 , pp. 586-590
    • Yaginuma, G.1    Mohri, H.2    Takahashi, T.3
  • 18
    • 0027350888 scopus 로고
    • Structure and pathogenesis of plexiform lesion in pulmonary hypertension
    • Ogata T., and Lijima T. Structure and pathogenesis of plexiform lesion in pulmonary hypertension. Chin Med J (Engl) 106 (1993) 45-48
    • (1993) Chin Med J (Engl) , vol.106 , pp. 45-48
    • Ogata, T.1    Lijima, T.2
  • 19
    • 0034107177 scopus 로고    scopus 로고
    • A spectrum of pulmonary vascular pathology in portopulmonary hypertension
    • Krowka M.J., and Edwards W.D. A spectrum of pulmonary vascular pathology in portopulmonary hypertension. Liver Transpl 6 (2000) 2421-2422
    • (2000) Liver Transpl , vol.6 , pp. 2421-2422
    • Krowka, M.J.1    Edwards, W.D.2
  • 20
    • 0027511942 scopus 로고
    • Thrombotic lesions in primary plexogenic arteriopathy. Similar pathogenesis or complication?
    • Wagenvort C.A., and Mulder P.G. Thrombotic lesions in primary plexogenic arteriopathy. Similar pathogenesis or complication?. Chest 103 (1993) 844-849
    • (1993) Chest , vol.103 , pp. 844-849
    • Wagenvort, C.A.1    Mulder, P.G.2
  • 21
    • 0026628265 scopus 로고
    • An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension
    • Christman B.W., Mcpherson C.D., Newman J.H., et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327 (1992) 70-75
    • (1992) N Engl J Med , vol.327 , pp. 70-75
    • Christman, B.W.1    Mcpherson, C.D.2    Newman, J.H.3
  • 22
    • 11444251239 scopus 로고    scopus 로고
    • Thromboxane-dependent portopulmonary hypertension
    • Maruyama T., Ohsaki K., Shimoda S., et al. Thromboxane-dependent portopulmonary hypertension. Am J Med 118 (2005) 93-94
    • (2005) Am J Med , vol.118 , pp. 93-94
    • Maruyama, T.1    Ohsaki, K.2    Shimoda, S.3
  • 23
    • 0041885258 scopus 로고    scopus 로고
    • Portopulmonary hypertension in decompensated cirrhosis with refractory ascites
    • Benjaminov F.S., Prentice M., Sniderman K.W., et al. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut 52 (2003) 1355-1362
    • (2003) Gut , vol.52 , pp. 1355-1362
    • Benjaminov, F.S.1    Prentice, M.2    Sniderman, K.W.3
  • 24
    • 0034776773 scopus 로고    scopus 로고
    • Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension
    • Eddahibi S., Humbert M., Fadel E., et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 108 (2001) 1141-1150
    • (2001) J Clin Invest , vol.108 , pp. 1141-1150
    • Eddahibi, S.1    Humbert, M.2    Fadel, E.3
  • 25
    • 0029033224 scopus 로고
    • Increased plasma serotonin in primary pulmonary hypertension
    • Herve P., Launay J.M., Scrobohaci M.L., et al. Increased plasma serotonin in primary pulmonary hypertension. Am J Med 99 (1995) 249-254
    • (1995) Am J Med , vol.99 , pp. 249-254
    • Herve, P.1    Launay, J.M.2    Scrobohaci, M.L.3
  • 26
    • 0033817459 scopus 로고    scopus 로고
    • Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium
    • Lane K.B., Machado R.D., Pauciulo M.W., et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 26 (2000) 81-84
    • (2000) Nat Genet , vol.26 , pp. 81-84
    • Lane, K.B.1    Machado, R.D.2    Pauciulo, M.W.3
  • 27
    • 0033838125 scopus 로고    scopus 로고
    • Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
    • Deng Z., Morse J.H., Slager S.L., et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 67 (2000) 737-744
    • (2000) Am J Hum Genet , vol.67 , pp. 737-744
    • Deng, Z.1    Morse, J.H.2    Slager, S.L.3
  • 28
    • 0020640953 scopus 로고
    • Primary pulmonary hypertension and cirrhosis: are they related?
    • McDonnell P., Toye P., and Hutchins G. Primary pulmonary hypertension and cirrhosis: are they related?. Am Rev Respir Dis 127 (1983) 437-441
    • (1983) Am Rev Respir Dis , vol.127 , pp. 437-441
    • McDonnell, P.1    Toye, P.2    Hutchins, G.3
  • 29
    • 0025977116 scopus 로고
    • Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics
    • Hadengue A., Benhayoun M.K., Lebrec D., et al. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 100 (1991) 520-528
    • (1991) Gastroenterology , vol.100 , pp. 520-528
    • Hadengue, A.1    Benhayoun, M.K.2    Lebrec, D.3
  • 30
    • 0035073798 scopus 로고    scopus 로고
    • Portopulmonary hypertension: distinctive hemodynamic and clinical manifestations
    • Yang Y.Y., Lin H.C., Lee W.C., et al. Portopulmonary hypertension: distinctive hemodynamic and clinical manifestations. J Gastroenterol 36 (2001) 181-186
    • (2001) J Gastroenterol , vol.36 , pp. 181-186
    • Yang, Y.Y.1    Lin, H.C.2    Lee, W.C.3
  • 31
    • 0030317077 scopus 로고    scopus 로고
    • Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients
    • Castro M., Krowka M.J., Schroeder D.R., et al. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc 71 (1996) 543-551
    • (1996) Mayo Clin Proc , vol.71 , pp. 543-551
    • Castro, M.1    Krowka, M.J.2    Schroeder, D.R.3
  • 32
    • 0035956866 scopus 로고    scopus 로고
    • Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates
    • Torregossa M., Genesca J., Gonzalez A., et al. Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates. Transplantation 71 (2001) 572-574
    • (2001) Transplantation , vol.71 , pp. 572-574
    • Torregossa, M.1    Genesca, J.2    Gonzalez, A.3
  • 33
    • 0030774349 scopus 로고    scopus 로고
    • Severe pulmonary hypertension in liver transplantation candidates
    • Ramsay M.A., Simpson B., Nguyen A.T., et al. Severe pulmonary hypertension in liver transplantation candidates. Liver Transpl Surg 3 (1997) 494-500
    • (1997) Liver Transpl Surg , vol.3 , pp. 494-500
    • Ramsay, M.A.1    Simpson, B.2    Nguyen, A.T.3
  • 34
    • 10244243860 scopus 로고    scopus 로고
    • Moderate primary pulmonary hypertension in patients undergoing liver transplantation
    • Taura P., Garcia-Valdecasas J.C., Beltran J., et al. Moderate primary pulmonary hypertension in patients undergoing liver transplantation. Anesth Analg 83 (1996) 675-680
    • (1996) Anesth Analg , vol.83 , pp. 675-680
    • Taura, P.1    Garcia-Valdecasas, J.C.2    Beltran, J.3
  • 35
    • 0027210789 scopus 로고
    • Successful liver transplantation in patients with mild to moderate pulmonary hypertension
    • [letter]
    • Plevak D., Krowka M.J., Rettke S., et al. Successful liver transplantation in patients with mild to moderate pulmonary hypertension. [letter]. Transplant Proc 25 (1993) 1840
    • (1993) Transplant Proc , vol.25 , pp. 1840
    • Plevak, D.1    Krowka, M.J.2    Rettke, S.3
  • 36
    • 0037311187 scopus 로고    scopus 로고
    • Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study
    • Colle I.O., Moreau R., Godinho E., et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study. Hepatology 37 (2003) 401-409
    • (2003) Hepatology , vol.37 , pp. 401-409
    • Colle, I.O.1    Moreau, R.2    Godinho, E.3
  • 37
    • 0029966397 scopus 로고    scopus 로고
    • Two-dimensional, and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation
    • Donovan C.L., Marcovitz P.A., Punch J.D., et al. Two-dimensional, and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 61 (1996) 1180-1188
    • (1996) Transplantation , vol.61 , pp. 1180-1188
    • Donovan, C.L.1    Marcovitz, P.A.2    Punch, J.D.3
  • 39
    • 0031844681 scopus 로고    scopus 로고
    • Pulmonary vascular disorders in portal hypertension
    • Herve P., Lebrec D., Brenot F., et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J 11 (1998) 1153-1166
    • (1998) Eur Respir J , vol.11 , pp. 1153-1166
    • Herve, P.1    Lebrec, D.2    Brenot, F.3
  • 40
    • 25144515518 scopus 로고    scopus 로고
    • Hemodyanamics and survival of patients with portopulmonary hypertension
    • Kawut S.M., Taichman D.B., Ahya V.N., et al. Hemodyanamics and survival of patients with portopulmonary hypertension. Liver Transpl 11 (2005) 1107-1111
    • (2005) Liver Transpl , vol.11 , pp. 1107-1111
    • Kawut, S.M.1    Taichman, D.B.2    Ahya, V.N.3
  • 41
    • 0034091316 scopus 로고    scopus 로고
    • Pulmonary hypertension
    • Krowka M.J. Pulmonary hypertension. Mayo Clin Proc 75 (2000) 625-630
    • (2000) Mayo Clin Proc , vol.75 , pp. 625-630
    • Krowka, M.J.1
  • 42
    • 0034722976 scopus 로고    scopus 로고
    • Pulmonary hypertension
    • Gaine S. Pulmonary hypertension. JAMA 284 (2000) 3160-3168
    • (2000) JAMA , vol.284 , pp. 3160-3168
    • Gaine, S.1
  • 43
    • 0019945282 scopus 로고
    • Pulmonary hypertension: its association with hepatic cirrhosis and iron accumulation
    • Molden D., and Abraham J.L. Pulmonary hypertension: its association with hepatic cirrhosis and iron accumulation. Arch Pathol Lab Med 106 (1982) 328-331
    • (1982) Arch Pathol Lab Med , vol.106 , pp. 328-331
    • Molden, D.1    Abraham, J.L.2
  • 44
    • 0030954241 scopus 로고    scopus 로고
    • Hepatapulmonary syndrome vs. portopulmonary hypertension: distinctions and dilemmas
    • Krowka M.J. Hepatapulmonary syndrome vs. portopulmonary hypertension: distinctions and dilemmas. Hepatology 25 (1997) 1282-1284
    • (1997) Hepatology , vol.25 , pp. 1282-1284
    • Krowka, M.J.1
  • 45
    • 0030773853 scopus 로고    scopus 로고
    • Distinctive clinical features of portopulmonary hypertension
    • Kuo P.C., Plotkin J.S., Johnson L.B., et al. Distinctive clinical features of portopulmonary hypertension. Chest 112 (1997) 980-986
    • (1997) Chest , vol.112 , pp. 980-986
    • Kuo, P.C.1    Plotkin, J.S.2    Johnson, L.B.3
  • 46
    • 0036283402 scopus 로고    scopus 로고
    • Arterial oxygenation associated with portopulmonary hypertension
    • Swanson K., and Krowka M. Arterial oxygenation associated with portopulmonary hypertension. Chest 121 (2002) 1869-1875
    • (2002) Chest , vol.121 , pp. 1869-1875
    • Swanson, K.1    Krowka, M.2
  • 47
    • 0023696294 scopus 로고
    • Pulmonary hypertension complicating portal hypertension: findings on chest radiographs
    • Chan T., Palevsky H.I., and Miller W.T. Pulmonary hypertension complicating portal hypertension: findings on chest radiographs. AJR Am J Roentgenol 151 (1988) 909-914
    • (1988) AJR Am J Roentgenol , vol.151 , pp. 909-914
    • Chan, T.1    Palevsky, H.I.2    Miller, W.T.3
  • 48
    • 17144452791 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension
    • Nagaya N., Nishikimi T., Okano Y., et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 31 (1998) 201-211
    • (1998) J Am Coll Cardiol , vol.31 , pp. 201-211
    • Nagaya, N.1    Nishikimi, T.2    Okano, Y.3
  • 49
    • 0033931829 scopus 로고    scopus 로고
    • Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates
    • Kim W.R., Krowka M.J., Plevak D.J., et al. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl 6 (2000) 453-458
    • (2000) Liver Transpl , vol.6 , pp. 453-458
    • Kim, W.R.1    Krowka, M.J.2    Plevak, D.J.3
  • 50
    • 0028944179 scopus 로고
    • Effects of nifedipine on hepatic venous pressure gradient and portal vein blood flow in patients with cirrhosis
    • Ota K., Shilo H., Kokawa H., et al. Effects of nifedipine on hepatic venous pressure gradient and portal vein blood flow in patients with cirrhosis. J Gastroenterol Hepatol 10 (1995) 198-204
    • (1995) J Gastroenterol Hepatol , vol.10 , pp. 198-204
    • Ota, K.1    Shilo, H.2    Kokawa, H.3
  • 51
    • 0023688192 scopus 로고
    • Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension
    • Navasa M., Bosch J., Reichen J., et al. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension. Hepatology 8 (1988) 850-854
    • (1988) Hepatology , vol.8 , pp. 850-854
    • Navasa, M.1    Bosch, J.2    Reichen, J.3
  • 52
    • 30044440867 scopus 로고    scopus 로고
    • Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension
    • Provencher S., Herve P., Jais X., et al. Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension. Gastroenterology 130 (2006) 120-126
    • (2006) Gastroenterology , vol.130 , pp. 120-126
    • Provencher, S.1    Herve, P.2    Jais, X.3
  • 53
    • 0037149718 scopus 로고    scopus 로고
    • Bosentan therapy for pulmonary arterial hypertension
    • Rubin L., Badesch D., Barst R., et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346 (2002) 896-903
    • (2002) N Engl J Med , vol.346 , pp. 896-903
    • Rubin, L.1    Badesch, D.2    Barst, R.3
  • 54
    • 3242762283 scopus 로고    scopus 로고
    • Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation
    • Makisalo H., Koivusalo A., Vakkuri A., et al. Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation. Liver Translp 10 (2004) 945-950
    • (2004) Liver Translp , vol.10 , pp. 945-950
    • Makisalo, H.1    Koivusalo, A.2    Vakkuri, A.3
  • 55
    • 2942639967 scopus 로고    scopus 로고
    • Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension
    • Halank M., Miehlke S., Hoeffken G., et al. Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension. Transplantation 77 (2004) 1775-1776
    • (2004) Transplantation , vol.77 , pp. 1775-1776
    • Halank, M.1    Miehlke, S.2    Hoeffken, G.3
  • 56
    • 9144272742 scopus 로고    scopus 로고
    • Endothelin-receptor antagonist treatment of portopulmonary hypertension
    • Hinterhuber L., Graziadei I.W., Kahler C.M., et al. Endothelin-receptor antagonist treatment of portopulmonary hypertension. Clin Gastroenterol Hepatol 2 (2004) 1039-1042
    • (2004) Clin Gastroenterol Hepatol , vol.2 , pp. 1039-1042
    • Hinterhuber, L.1    Graziadei, I.W.2    Kahler, C.M.3
  • 57
    • 11144259340 scopus 로고    scopus 로고
    • Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: a safe and effective therapy?
    • Kuntzen C., Gulberg V., and Gerbes A.L. Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: a safe and effective therapy?. Gastroenterology 128 (2005) 164-168
    • (2005) Gastroenterology , vol.128 , pp. 164-168
    • Kuntzen, C.1    Gulberg, V.2    Gerbes, A.L.3
  • 58
    • 14744304820 scopus 로고    scopus 로고
    • Bosentan therapy for portopulmonary hypertension
    • Hoeper M.M., Halank M., Marx C., et al. Bosentan therapy for portopulmonary hypertension. Eur Respir J 25 (2005) 502-508
    • (2005) Eur Respir J , vol.25 , pp. 502-508
    • Hoeper, M.M.1    Halank, M.2    Marx, C.3
  • 59
    • 24744458364 scopus 로고    scopus 로고
    • Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan
    • Halank M., Kolditz M., Miehlke S., et al. Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan. Wein Med Wochenschr 155 (2005) 376-380
    • (2005) Wein Med Wochenschr , vol.155 , pp. 376-380
    • Halank, M.1    Kolditz, M.2    Miehlke, S.3
  • 60
    • 26444534291 scopus 로고    scopus 로고
    • Sildenafil citrate therapy for pulmonary arterial hypertension
    • Galie N., Ghofrani H.A., Torbicki A., et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353 (2005) 2148-2157
    • (2005) N Engl J Med , vol.353 , pp. 2148-2157
    • Galie, N.1    Ghofrani, H.A.2    Torbicki, A.3
  • 61
    • 15544369773 scopus 로고    scopus 로고
    • Novel use of sildenafil in the treatment of portopulmonary hypertension
    • Chua R., Keogh A., and Miyashita M. Novel use of sildenafil in the treatment of portopulmonary hypertension. J Heart Lung Transplant 24 (2005) 498-500
    • (2005) J Heart Lung Transplant , vol.24 , pp. 498-500
    • Chua, R.1    Keogh, A.2    Miyashita, M.3
  • 62
    • 0036682273 scopus 로고    scopus 로고
    • Inhaled iloprost for severe pulmonary hypertension
    • Olschewski H., Simonneau G., Galie N., et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 347 (2002) 322-329
    • (2002) N Engl J Med , vol.347 , pp. 322-329
    • Olschewski, H.1    Simonneau, G.2    Galie, N.3
  • 63
    • 0037086133 scopus 로고    scopus 로고
    • Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial
    • Simonneau G., Barst R.J., Galie N., et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 165 (2002) 800-804
    • (2002) Am J Respir Crit Care Med , vol.165 , pp. 800-804
    • Simonneau, G.1    Barst, R.J.2    Galie, N.3
  • 64
    • 0030031888 scopus 로고    scopus 로고
    • A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group
    • Barst R.J., Rubin L.J., Long W.A., et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 334 (1996) 296-302
    • (1996) N Engl J Med , vol.334 , pp. 296-302
    • Barst, R.J.1    Rubin, L.J.2    Long, W.A.3
  • 65
    • 0031041342 scopus 로고    scopus 로고
    • Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension
    • Kuo P.C., Johnson L.B., Plotkin J.S., et al. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 63 (1997) 604-606
    • (1997) Transplantation , vol.63 , pp. 604-606
    • Kuo, P.C.1    Johnson, L.B.2    Plotkin, J.S.3
  • 66
    • 0032870286 scopus 로고    scopus 로고
    • Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension
    • Krowka M.J., Frantz R.P., McGoon M.D., et al. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology 30 (1999) 641-648
    • (1999) Hepatology , vol.30 , pp. 641-648
    • Krowka, M.J.1    Frantz, R.P.2    McGoon, M.D.3
  • 67
    • 0032833889 scopus 로고    scopus 로고
    • Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension
    • Findlay J.Y., Plevak D.J., Krowka M.J., et al. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension. Liver Transpl Surg 5 (1999) 362-365
    • (1999) Liver Transpl Surg , vol.5 , pp. 362-365
    • Findlay, J.Y.1    Plevak, D.J.2    Krowka, M.J.3
  • 68
    • 11344278652 scopus 로고    scopus 로고
    • Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertension
    • Halank M., Marx C., Miehlke S., et al. Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertension. J Gastroenterol 39 (2004) 1222-1223
    • (2004) J Gastroenterol , vol.39 , pp. 1222-1223
    • Halank, M.1    Marx, C.2    Miehlke, S.3
  • 69
    • 0033915234 scopus 로고    scopus 로고
    • Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation
    • Krowka M., Plevak D., Findlay J., et al. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 6 (2000) 443-450
    • (2000) Liver Transpl , vol.6 , pp. 443-450
    • Krowka, M.1    Plevak, D.2    Findlay, J.3
  • 70
    • 11844268031 scopus 로고    scopus 로고
    • New predictors of outcome in idiopathic pulmonary arterial hypertension
    • Kawut S., Horn E., Berekashvili K., et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 95 (2005) 199-203
    • (2005) Am J Cardiol , vol.95 , pp. 199-203
    • Kawut, S.1    Horn, E.2    Berekashvili, K.3
  • 71
    • 0037126044 scopus 로고    scopus 로고
    • Survival in primary pulmonary hypertension: the impact of epoprostenol therapy
    • Mclaughlin V., Shillington A., and Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 106 (2002) 1477-1482
    • (2002) Circulation , vol.106 , pp. 1477-1482
    • Mclaughlin, V.1    Shillington, A.2    Rich, S.3
  • 72
    • 0037151645 scopus 로고    scopus 로고
    • Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival
    • Sitbon O., Humbert M., Nunes H., et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 40 (2002) 780-788
    • (2002) J Am Coll Cardiol , vol.40 , pp. 780-788
    • Sitbon, O.1    Humbert, M.2    Nunes, H.3
  • 73
    • 0036245134 scopus 로고    scopus 로고
    • Outcome of liver transplantation for patients with pulmonary hypertension
    • Starkel P., Vera A., Gunson B., et al. Outcome of liver transplantation for patients with pulmonary hypertension. Liver Transpl 8 (2002) 382-388
    • (2002) Liver Transpl , vol.8 , pp. 382-388
    • Starkel, P.1    Vera, A.2    Gunson, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.